Laura Sepp-Lorenzino

Laura Sepp-Lorenzino, Ph.D. is currently the Chief Scientific Officer at Intellia Therapeutics, Inc. Laura has a vast experience in the field, working in various high-level positions at companies such as Vertex Pharmaceuticals, Alnylam Pharmaceuticals, Merck, and Third Rock Ventures. Their expertise includes RNA therapeutics, infectious diseases, oncology, and biologics research. Laura holds a Ph.D. in Biochemistry from New York University and a Biochemist degree from the University of Buenos Aires.